Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 03, 2021

SELL
$9.85 - $17.69 $289,875 - $520,599
-29,429 Closed
0 $0
Q4 2020

Jan 15, 2021

BUY
$14.15 - $17.19 $416,420 - $505,884
29,429 New
29,429 $456,000
Q1 2020

Apr 15, 2020

SELL
$14.38 - $27.72 $1.5 Million - $2.89 Million
-104,100 Closed
0 $0
Q4 2019

Jan 09, 2020

SELL
$9.23 - $19.67 $121,374 - $258,660
-13,150 Reduced 11.22%
104,100 $2 Million
Q3 2019

Oct 15, 2019

SELL
$5.66 - $11.85 $2.32 Million - $4.85 Million
-409,650 Reduced 77.75%
117,250 $1.13 Million
Q2 2019

Jul 18, 2019

BUY
$4.32 - $6.43 $354,240 - $527,260
82,000 Added 18.43%
526,900 $3.16 Million
Q4 2018

Jan 14, 2019

SELL
$8.2 - $16.95 $237,808 - $491,566
-29,001 Reduced 6.12%
444,900 $4.17 Million
Q3 2018

Oct 16, 2018

BUY
$17.03 - $21.18 $8.07 Million - $10 Million
473,901 New
473,901 $8.07 Million
Q3 2018

Oct 12, 2018

SELL
$17.03 - $21.18 $7.1 Million - $8.83 Million
-416,900 Closed
0 $0
Q2 2018

Jul 10, 2018

BUY
$12.0 - $19.88 $5 Million - $8.29 Million
416,900 New
416,900 $7.08 Million

Others Institutions Holding KPTI

About Karyopharm Therapeutics Inc.


  • Ticker KPTI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 79,806,600
  • Market Cap $611M
  • Description
  • Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company, discovers, develops, and commercializes drugs directed against nuclear export for the treatment of cancer and other diseases. The company discovers, develops, and commercializes novel and Selective Inhibitor of Nuclear Export (SINE) compounds function by binding with and in...
More about KPTI
Track This Portfolio

Track Private Capital Advisors, Inc. Portfolio

Follow Private Capital Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Private Capital Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Private Capital Advisors, Inc. with notifications on news.